I was listening to Freakoconomics on NPR the other day -commercial medical AI applications were being discussed. Most of the real value has been realized in this field, especially with diagnostic vision models. I had a open assignment project in a deep learning class. Because three suspicious moles had just appeared on my forearm, I used a Kaggle melanoma competition CNN TensorFlow solution from an Egyptian master. His model had good accuracy and precision. I improved that marginally, but the winners used a multimodal parallel neural network which considered meta data of each patient besides the image of their lesion.
My intent was to roll one of the best models into a container and publish a self diagnosis web app – since the lead time for an initial dermatologist appointment was two months. The five week course ended and I looked at my forearm. There were faint pink scars where there had been moles .The three suspicious lesions had spontaneously healed. Had looking at the dataset (60,000 mole images)and contemplating the subject activated a top-down immunological solution in the problem space my organism?
Who knows?
I realized that such a self diagnostic app would be harmful – it could discourage some from ever seeing a physician. But I know how to put it to good use. As a scheduling triage intervention- a patient whose lesion is predicted to be malignant will be rescheduled with urgency when there are cancellations. Management – Intervention tools such as this have become prominent in the Canadian health system.
Freakonomics mentioned the singular medical records behemoth Epic. The target application will be a white label app that can be ported to their platform. I will be experimenting with building some software developing agents. I’ll tune the language interpretation first, then use it on the Melanoma Intervention Scheduler developing its libraries and parameters.
I watched Wes Roth extol Opus 4.6 for its tenacity and rule being. So it sounds like the right fit for an advocate that needs to file ethics complaints and lawsuits-
It is. Here’s what Opus 4.6 made of my github and the three previous blog posts;
Anthropic hit a snag when owner Dario Amodei refused to capitulate to Defense Secretary Pete Hegseth on automated weapons and surveillance. The dispute and government response were performative however, Max Tegmark points out that Amodei could have lobbied for just such prohibitions when he was instead pushing for no regulation. The president forbid use of Anthropic but it’s use continues in the Iran war. The two parties seem ill fated to have a harmonious outcome to such a dispute: Amodei is neuro diverse and Hegseth an outspoken alpha. They would both have been better served by consulting Opus 4.6 on their responses to one another. Strategic Diplomatic Consultancy is an untapped potential of Opus 4.6 and Gemini. I am interested to see the Rand Corporation’s and the World Bank’s projections for potential global economic impact of such application over a number of years.